[ Special series on Breast Cancer ]
doi: 10.1186/s40880-017-0204-9
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Dong Wang, Ruikai Du and Suling Liu
The CAS Key Laboratory of Innate Immunity and Chronic Disease, Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Science and Medical Center, University of Science & Technology of China
Chinese Journal of Cancer 2017, Volume: 36, Issue 6
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)
[Google Scholar]
[ More articles of the special series on Breast Cancer ]
Cite this article
Dong Wang, Ruikai Du and Suling Liu. Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer. Chin J Cancer. 2017, 36:37. doi:10.1186/s40880-017-0204-9
Export citations
EndNote
[ Html full-text / Citation export] (BioMed Central)
[Google Scholar]
[ More articles of the special series on Breast Cancer ]
Cite this article
Dong Wang, Ruikai Du and Suling Liu. Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer. Chin J Cancer. 2017, 36:37. doi:10.1186/s40880-017-0204-9
Export citations
EndNote
SHARE THIS ARTICLE
Comments:
